Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 9 studies | 78% ± 13% | |
| retinal rod cell | 9 studies | 72% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 6 studies | 48% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 98% | 77.65 | 448 / 459 | 31% | 0.62 | 343 / 1118 |
| kidney | 99% | 68.81 | 88 / 89 | 19% | 0.33 | 168 / 901 |
| esophagus | 92% | 28.34 | 1323 / 1445 | 22% | 0.35 | 41 / 183 |
| lung | 99% | 82.96 | 574 / 578 | 8% | 0.20 | 97 / 1155 |
| pancreas | 99% | 48.08 | 326 / 328 | 8% | 0.18 | 14 / 178 |
| prostate | 96% | 39.74 | 236 / 245 | 10% | 0.17 | 50 / 502 |
| brain | 97% | 137.36 | 2555 / 2642 | 6% | 0.08 | 45 / 705 |
| thymus | 99% | 61.57 | 649 / 653 | 3% | 0.03 | 16 / 605 |
| stomach | 92% | 34.61 | 329 / 359 | 7% | 0.16 | 20 / 286 |
| intestine | 95% | 39.40 | 918 / 966 | 3% | 0.05 | 17 / 527 |
| uterus | 94% | 35.39 | 160 / 170 | 4% | 0.08 | 17 / 459 |
| blood vessel | 97% | 40.19 | 1297 / 1335 | 0% | 0 | 0 / 0 |
| bladder | 90% | 37.90 | 19 / 21 | 5% | 0.10 | 24 / 504 |
| skin | 92% | 39.93 | 1660 / 1809 | 0% | 0 | 0 / 472 |
| adipose | 91% | 36.01 | 1097 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 90% | 29.71 | 218 / 241 | 0% | 0 | 0 / 0 |
| heart | 77% | 18.68 | 666 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 76% | 15.81 | 195 / 258 | 0% | 0 | 0 / 230 |
| ovary | 71% | 16.60 | 128 / 180 | 1% | 0.01 | 3 / 430 |
| liver | 60% | 11.29 | 135 / 226 | 0% | 0.01 | 2 / 406 |
| muscle | 43% | 7.24 | 344 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 14% | 4.19 | 134 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 9% | 4.21 | 7 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0033165 | Cellular component | interphotoreceptor matrix |
| GO_0001750 | Cellular component | photoreceptor outer segment |
| GO_0001917 | Cellular component | photoreceptor inner segment |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0008201 | Molecular function | heparin binding |
| GO_0035374 | Molecular function | chondroitin sulfate binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| Gene name | IMPG1 |
| Protein name | Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa) (IPM-150) (Sialoprotein associated with cones and rods) Interphotoreceptor matrix proteoglycan 1 (Sialoprotein associated with cones and rods) Interphotoreceptor matrix proteoglycan 1 |
| Synonyms | IPM150 SPACR |
| Description | FUNCTION: Chondroitin sulfate-, heparin- and hyaluronan-binding protein (By similarity). May serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix . . |
| Accessions | ENST00000611179.4 ENST00000369963.5 ENST00000369950.8 [Q17R60-1] A0A0R4J2E9 Q5JSC4 A0A087WYL3 ENST00000369952.3 Q17R60 |